Clinical trial · Interventional
Pharmacist's Influence on Breast Cancer Patient Quality of Life
Influence of a Clinical Pharmacist's Intervention on Quality of Life of a Breast Cancer Patient Under Adjuvant Chemotherapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to investigate the impact of pharmacist behavioral intervention's influence on breast cancer patients' quality of life. Croatian randomized controlled trial. Targeted population: general population of breast cancer patients under the first adjuvant anthracycline chemotherapy. Primary outcome: difference in EORTC QLQ-BR23 questionnaire result from the baseline to after 3 week cycle.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer, Quality of Life | Malignant Breast Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Pharmacist's behavioral intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Under pharmacist's behavioral intervention
- interventionNames
- Behavioral: Pharmacist's behavioral intervention
- type
- NO_INTERVENTION
- label
- Control
- description
- No pharmacist's behavioral intervention
Primary outcomes (1)
- measure
- changes in quality of life of a breast cancer patient under chemotherapy, after a clinical pharmacist's behavioral intervention, measured by EORTC B23 questionnaire
- timeFrame
- up to two months
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * Early breast cancer * First adjuvant chemotherapy * Chemotherapy protocol: anthracycline x 4 Exclusion Criteria: * Cardiovascular comorbidities * Regular nausea or vomiting during six months before enrollment * Unable to answer the quality of life questionnaire on their own
References
Publications (0)
Data not yet available